Mainstream

Surgery Partners reiterates 2025 guidance, targets $3.3B–$3.45B revenue while expanding high acuity and de novo growth

Surgery Partners reiterates 2025 guidance, targets $3.3B–$3.45B revenue while expanding high acuity and de novo growth

Post ContentsgryRead More

You might also be interested in reading Ripple CTO Advises Selling Flare (FLR) Tokens, Raises Serious Allegations.

May 12, 2025
In Mainstream